Characteristics and short-term obstetric outcomes in a case series of 67 women test-positive for SARS-CoV-2 in Stockholm, Sweden.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
12 2020
Historique:
received: 18 06 2020
revised: 14 09 2020
accepted: 22 09 2020
pubmed: 28 9 2020
medline: 15 12 2020
entrez: 27 9 2020
Statut: ppublish

Résumé

The Stockholm region was the first area in Sweden to be hit by the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The national guidelines on the care of women with a positive test for SARS-CoV-2 (detection with polymerase chain reaction [PCR]) recommend individualized antenatal care, mode of delivery based on obstetric considerations, and no routine separation of the mother and the newborn. Breastfeeding is encouraged, and although there is no specific recommendation regarding wearing a face mask to prevent viral transmission to the newborn while nursing, instructions are given to keep high hygiene standards. All studies based on cases tested on hospital admission will capture more women with pregnancy complications than in the general population. Our aim was to describe the clinical characteristics of SARS-CoV-2-positive women and their neonates, and to report short-term maternal and neonatal outcomes. A retrospective case series with data from medical records including all test-positive women (n = 67) who gave birth to 68 neonates from 19 March to 26 April 2020 in Stockholm, Sweden. Means, proportions and percentages were calculated for clinical characteristics and outcomes. The mean age was 32 years, 40% were nulliparous and 61% were overweight or obese. Further, 15% had diabetes and 21% a hypertensive disease. Seventy percent of the women had a vaginal birth. Preterm delivery occurred in 19% of the women. The preterm deliveries were mostly medically indicated, including two women who were delivered preterm due to severe coronavirus disease 19 (COVID-19), corresponding to 15% of the preterm births. Four women (6%) were admitted to the intensive care unit postpartum but there were no maternal deaths. There were two perinatal deaths (one stillbirth and one neonatal death). Three neonates were PCR-positive for SARS-CoV-2 after birth. In this case series of 67 women testing positive for SARS-CoV-2 with clinical presentations ranging from asymptomatic to manifest COVID-19 disease, few women presented with severe COVID-19 illness. The majority had a vaginal birth at term with a healthy neonate that was negative for SARS-CoV-2.

Identifiants

pubmed: 32981033
doi: 10.1111/aogs.14006
pmc: PMC7537005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1626-1631

Informations de copyright

© 2020 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG.

Références

J Gynecol Obstet Hum Reprod. 2020 Sep;49(7):101826
pubmed: 32505805
Acta Obstet Gynecol Scand. 2020 Jul;99(7):948-949
pubmed: 32249924
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
Lakartidningen. 2019 Oct 8;116:
pubmed: 31593290
BJOG. 2020 Aug;127(9):1109-1115
pubmed: 32369656
Acta Obstet Gynecol Scand. 2018 Apr;97(4):466-476
pubmed: 29172245
Am J Obstet Gynecol. 2020 Dec;223(6):914.e1-914.e15
pubmed: 32553908
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
BJOG. 2020 Aug;127(9):1116-1121
pubmed: 32339382
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
Acta Obstet Gynecol Scand. 2020 Dec;99(12):1626-1631
pubmed: 32981033
J Matern Fetal Neonatal Med. 2022 Apr;35(8):1619-1622
pubmed: 32354293
Arch Pathol Lab Med. 2020 Apr 27;:
pubmed: 32338533
JAMA. 2020 Nov 3;324(17):1782-1785
pubmed: 32965467
Geburtshilfe Frauenheilkd. 2020 Apr;80(4):380-390
pubmed: 32322107
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Lancet Diabetes Endocrinol. 2016 Dec;4(12):1025-1036
pubmed: 27743975
Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4
pubmed: 32376317

Auteurs

Katarina Remaeus (K)

BB Stockholm, Danderyd Hospital, Stockholm, Sweden.
Department of Medicine Solna, Clinical Epidemiology division, Karolinska Institutet, Stockholm, Sweden.

Julia Savchenko (J)

Department of Obstetrics and Gynecology, Södersjukhuset Hospital, Stockholm, Sweden.
Department of Clinical Science and Education, Södersjukhuset Hospital, Karolinska Institutet, Stockholm, Sweden.

Sophia Brismar Wendel (S)

Department of Obstetrics and Gynecology, Danderyd Hospital, Stockholm, Sweden.
Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

Sebastian Brusell Gidlöf (S)

Department of Obstetrics and Gynecology, Södersjukhuset Hospital, Stockholm, Sweden.
Department for Clinical Intervention, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.

Sophie Graner (S)

BB Stockholm, Danderyd Hospital, Stockholm, Sweden.
Department of Medicine, Center for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Elin Jones (E)

Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.

Johanna Molin (J)

Department of Women's and Children's Health, Södertälje Hospital, Stockholm, Sweden.

Sissel Saltvedt (S)

Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

Tove Wallström (T)

Department of Obstetrics and Gynecology, Södersjukhuset Hospital, Stockholm, Sweden.
Department of Clinical Science and Education, Södersjukhuset Hospital, Karolinska Institutet, Stockholm, Sweden.

Karin Pettersson (K)

Department for Clinical Intervention, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.
Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH